Specimen index
Peptide Database
5 peptides — filtered results
Adrenomedullin
Phase IIAM
Adrenomedullin is a 52-amino-acid vasoactive peptide originally isolated from human pheochromocytoma. It is a potent vasodilator acting through CGRP receptors, promotes natriuresis, reduces inflammation, protects vascular endothelial barrier function, and enhances wound healing. Circulating AM levels rise in heart failure, sepsis, and critical illness — making it both a biomarker and emerging therapeutic target.
Apelin
Phase IAPLNR ligand · apelin-13
Apelin is an endogenous peptide that acts as the ligand for the APJ receptor (APLNR), a GPCR expressed throughout the cardiovascular system. It improves cardiac output and vascular tone through both positive inotropy and vasodilation, increases nitric oxide production, and reduces oxidative stress. Research focuses on heart failure, pulmonary arterial hypertension, and its potential to replace or complement established cardiac peptides.
Bradykinin
PreclinicalBK · Kallidin precursor fragment
Bradykinin is a 9-amino-acid vasoactive peptide of the kinin-kallikrein system. It produces vasodilation, increased vascular permeability, pain, and inflammation by acting on B1 and B2 receptors. ACE inhibitors (a major drug class) lower blood pressure partly by preventing bradykinin degradation. Icatibant, a B2 antagonist, is approved for hereditary angioedema. Research also implicates bradykinin in COVID-19 pathology (bradykinin storm hypothesis).
Endothelin-1
PreclinicalET-1 · Big endothelin-1
Endothelin-1 (ET-1) is a 21-amino-acid vasoconstrictor peptide produced primarily by vascular endothelial cells. It is the most potent endogenous vasoconstrictor known, acting through ETA and ETB receptors on vascular smooth muscle and endothelium. Elevated ET-1 is implicated in pulmonary arterial hypertension, heart failure, and renal disease — driving the development of endothelin receptor antagonists (bosentan, ambrisentan, macitentan) as clinical drugs.
TB-500
PreclinicalThymosin Beta-4 Fragment · Tβ4 fragment
TB-500 is a synthetic version of the active region of Thymosin Beta-4, a naturally occurring peptide found in virtually all human cells. Research shows it promotes actin polymerization and cell migration, which accelerates wound healing, muscle repair, and vascular growth. It is particularly studied for its ability to reduce inflammation and promote cardiac tissue repair.
C₂₁₂H₃₅₀N₅₆O₇₈S · 4963.44 Da